Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-hodgkin's lymphoma

Julie M. Vose, David Colcher, Lisa Gobar, Philip J. Bierman, Samuel Augustine, Margaret Tempero, Peter Leichner, James C. Lynch, David Goldenberg, James O. Armitage

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II trial of multiple dose <sup>131</sup>Iodine-MAb LL2 (CD22) in patients with recurrent non-hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences